Cargando…
Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
BACKGROUND: End-stage renal disease is primarily caused by diabetic kidney disease (DKD). The Farnesoid X receptor (FXR), a member of the nuclear receptor superfamily, has anti-inflammatory, lipid-lowering and hypoglycemic properties. It also inhibits renal fibrosis. Although its physiological role...
Autores principales: | Qiu, Yuxiang, Kang, Ningsu, Wang, Xi, Yao, Yao, Cui, Jun, Zhang, Xiaoyan, Zheng, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544308/ https://www.ncbi.nlm.nih.gov/pubmed/37790634 http://dx.doi.org/10.7717/peerj.16155 |
Ejemplares similares
-
Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021) -
Recombinant fusion protein by lysozyme and antibacterial peptide enhances ischemic wound healing via angiogenesis and reduction of inflammation in diabetic db/db mice
por: Li, Wei, et al.
Publicado: (2021) -
Effect of dark sweet cherry powder consumption on the gut microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice
por: Garcia-Mazcorro, Jose F., et al.
Publicado: (2018) -
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011) -
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)